OTC specialist Perrigo nabs Elan and its tax rate for $8.6B

Tracy Staton Perrigo has snatched up Elan for $ 8.6 billion in a cash-and-stock deal. Call it a case of opposites attracting: U.S.-based Perrigo specializes in cheap, store-brand generics, ...

U.S. court upturns Teva’s patents on cash-cow Copaxone

Tracy Staton A U.S. appeals court invalidated a patent protecting Copaxone till 2015–and that means Teva could face generic competition for its biggest drug next May. FiercePharma ...

FDA Approves Fetzima for MDD in Adults

mia.burns Forest Laboratories and Pierre Fabre Laboratories Announce FDA Approval of FETZIMA™ for the Treatment of Major Depressive Disorder in Adults NEW YORK & CASTRES, ...

Blue Cross Blue Shield of Michigan saves an estimated $155 million over three years from Patient-Centered Medical Home program

barbara.lempert Largest PCMH program in the nation yields improvements in quality and preventive care DETROIT, July 8, 2013 /PRNewswire/ — Blue Cross Blue Shield of Michigan ...

Quintiles report explains how healthcare executives can improve success

mia.burns By Mia Burns Healthcare industry executives’ understanding of the need to collaborate and the challenges they face in working together are explored in a new report from ...

Novartis’ Bexsero left off U.K. immunization schedule

Carly Helfand Novartis' Bexsero may be the only vaccine approved for life-threatening meningitis B, but that wasn't enough to convince the U.K.'s Joint Committee on Vaccination ...

Pfizer licenses antibody tech from Atlas-backed startup Harbour

Ryan McBride Harbour Antibodies has added to a list of pharma partners for its transgenic mouse technology for producing human antibodies. Pfizer has licensed the company's mice ...

Pharmalot… Pharmalittle… Good Morning

esilverman Hello, everyone, and nice to see you again. As you can see, we have returned from an extended weekend during which we accomplished several things on our to-do list. ...

Isis: Drug Reduces Triglycerides Up to 70 Percent

barbara.lempert Reports Phase 2 Data on ISIS-APOCIII Rx Showing Significant Reductions of ApoC-III and Triglycerides in Patients With High Triglycerides Taking Fibrates Reductions ...

Mallinckrodt Pays $3.5M To Settle Kickback Charges

esilverman Three days after the US Department of Justice formally joined a whistleblower lawsuit against Mallinckrodt, the drugmaker has agreed to pay $ 3.5 million to settle ...

Par Pharmaceutical Begins Shipment of Generic Trilipix

barbara.lempert Par Pharmaceutical Begins Shipment of Generic Trilipix® WOODCLIFF LAKE, N.J., July 18, 2013 /PRNewswire/ — Par Pharmaceutical Companies, Inc. today announced ...

Alzheimer’s roundup: Investigators carve out small gains against a brutal disease

John Carroll Alzheimer's was in the spotlight this week as investigators gathered at the annual Alzheimer's Association International Conference in Boston to ponder the latest ...
Page 20 of 34« First...10...1819202122...30...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS